| Display title | Chemistry:5-HT2C receptor agonist |
| Default sort key | 5-HT2C receptor agonist |
| Page length (in bytes) | 49,421 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 356674 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>Wincert |
| Date of page creation | 05:40, 6 February 2024 |
| Latest editor | imported>Wincert |
| Date of latest edit | 05:40, 6 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | 5-HT2C receptor agonists are a class of drugs that activate 5-HT2C receptors. They have been investigated for the treatment of a number of conditions including obesity, psychiatric disorders, sexual dysfunction and urinary incontinence.
The 5-HT2C receptors are one of three subtypes that belong to the... |
